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OBJECTIVES The study explored the potential for tissue swelling and venous occlusion during radiofre-
quency (RF) catheter ablation procedures using intracardiac echocardiography (ICE).
BACKGROUND Transient superior vena cava occlusion has been reported following catheter ablation
procedures for inappropriate sinus tachycardia (IST). Presumably, venous occlusion could
occur owing to thrombus formation or tissue swelling with resultant narrowing of the superior
vena cava–right atrial (SVC-RA) junction.
METHODS Intracardiac echocardiography (9 MHz) was used to guide ablation catheter position and for
continuous monitoring during RF application in 13 ablation procedures in 10 patients with
IST. The SVC-RA junction was measured prior to and following ablation. Successful
ablation was marked by abrupt reduction in the sinus rate and a change to a superiorly
directed p-wave axis.
RESULTS Eleven of 13 procedures were successful, requiring 29 6 20 RF lesions. Prior to the delivery
of RF lesions, the SVC-RA junction measured 16.4 6 2.9 mm. With RF delivery, local and
circumferential swelling was observed, causing progressive reduction in the diameter of the
SVC-RA junction to 12.6 6 3.3 mm (24% reduction, p 5 0.0001). A reduction in SVC-RA
orifice diameter of $30% compared to baseline was observed in five patients.
CONCLUSIONS The delivery of multiple RF ablation lesions, often necessary for cure of IST, can cause
considerable atrial swelling and resultant narrowing of the SVC-RA junction. Smaller venous
structures, such as the coronary sinus and the pulmonary veins, would also be expected to be
vulnerable to this complication. Thus, ICE imaging may be helpful in preventing excessive
tissue swelling leading to venous occlusion during catheter ablation procedures. (J Am Coll
Cardiol 1999;33:1667–70) © 1999 by the American College of Cardiology
Intracardiac echocardiography (ICE) is an emerging tech-
nology with considerable promise for assisting interven-
tional electrophysiology procedures. Investigators to date
have focused attention on the use of ICE to improve
procedural efficacy, either by providing better anatomic
characterization of the electrophysiologic substrate or to
monitor electrode-tissue contact (1–8). Little information is
available on the use of ICE to monitor and/or prevent the
development of complications during catheter ablation.
Transient superior vena cava (SVC) occlusion has been
reported following catheter ablation for inappropriate sinus
tachycardia (IST) (3). Presumably, venous occlusion could
occur on the basis of radiofrequency (RF) lesion-induced
tissue swelling and/or development of thrombus. Smaller-
diameter venous structures, such as the coronary sinus and
the pulmonary veins, may be expected to be subject to even
greater risk of occlusion with ablation procedures performed
in adjacent tissue (9).
To determine whether RF lesion-induced tissue swelling
is a plausible mechanism for venous occlusion and to assess
whether ICE might be useful in monitoring this potential
complication, we measured the effect of RF lesion delivery
on the orifice size of the SVC–right atrial (SVC-RA)
junction in patients undergoing ablation for IST.
METHODS
Patient population. Ten patients referred for catheter
ablation of IST performed under ICE guidance were
included in the study (May 1996 to January 1998). All
patients had paroxysmal palpitations, and five had a history
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of syncope. All patients failed drug therapy including
beta-adrenergic blocking agents (n 5 10), antiarrhythmic
agents (n 5 8) and calcium antagonists (n 5 5) before
ablation attempts. Previous His bundle ablation and at-
tempts at sinus node modification had been performed
before referral to our institution in two and three patients,
respectively. The mean age was 28 6 7 years and nine of the
patients were women. Before electrophysiologic study, all
patients had ambulatory monitor tracings demonstrating
paroxysmal supraventricular tachycardias, which corre-
sponded to symptomatic episodes. Noninvasive sinus node
function testing, including exercise testing, response to
graded doses of isoproterenol and intrinsic heart rate under
autonomic blockade (10,11), was performed in all patients
and demonstrated either abnormalities in resting rate and/or
inappropriate response to catecholamine infusion or exer-
cise. A total of 13 ablation procedures were performed in the
10 patients, with repeat procedures required for initial
failure (n 5 2) or recurrent symptoms following an initially
successful ablation (n 5 1).
Electrophysiologic study and ablation. Informed consent
was obtained from all patients before the procedure. Pa-
tients were studied in the postabsorptive state under condi-
tions of conscious sedation obtained by intravenous infusion
of midazolam and short-acting narcotic. Catheters were
inserted through the femoral and left basilic veins and
positioned under fluoroscopic and ICE guidance to the high
right atrium, atrioventricular junction and right ventricular
apex. A steerable thermistor-equipped catheter with either a
4- or 8-mm tip electrode was used for mapping and ablation
(EP Technologies, San Jose, California); the 8-mm tip was
used preferentially to facilitate visualization with ICE im-
aging. Surface leads and intracardiac electrograms filtered
from 30 Hz to 250 Hz were displayed and recorded using a
digital amplifier/recorder system. Episodes of IST, if not
present spontaneously, were induced with graded infusion
of isoproterenol. Although the mapping and ablation pro-
cedure was primarily anatomically based, electrophysiologic
mapping of the earliest atrial activation during episodes of
IST was performed for confirmation of the appropriateness
of ablation site targets using one or more of the following
techniques: 1) sequential multisite mapping using the abla-
tion catheter; 2) multisite simultaneous mapping using a
multipolar “crista” catheter (Webster Laboratories, Baldwin
Park, California), or 3) nonfluoroscopic, electroanatomic
mapping for right atrial activation (CARTO™, Biosense
Ltd., Israel).
Radiofrequency energy was delivered in a unipolar fash-
ion to areas of the superior lateral crista terminalis, demon-
strating earliest activation during sinus tachycardia. High
output pacing (10 mA, 2 ms pulse width) was performed at
all prospective RF target sites to ensure that diaphragmatic
stimulation did not occur, indicating the potential for
RF-induced damage to the phrenic nerve. The RF power
was adjusted to achieve a tip temperature of 50 to 55° and/or
a specified impedance drop from baseline (measured at 5-W
output, 10-ohm drop with a 4-mm tip electrode and 5 ohms
with an 8-mm tip), and applied for 120 s. Procedural success
was defined by the following: 1) an abrupt decrease ($30 bpm)
in sinus rate during RF lesion delivery; 2) the sudden
appearance of superiorly directed p-wave morphology (neg-
ative p wave in lead III); and 3) the persistence of these
features despite infusion of isoproterenol (up to 4 mcg/min)
for at least 30 min following the delivery of the final RF
lesion.
ICE imaging and data acquisition. Intracardiac echocar-
diography was performed using a 9-MHz rotating ultra-
sound transducer, mounted at the distal end of a 9F,
110-cm catheter (Boston Scientific Co., Watertown, Mas-
sachusetts). Images were acquired using a Sonos Intravas-
cular Imaging System (Hewlett-Packard, Andover, Massa-
chusetts). The transducer provides circular images at a rate
of up to 30 frames/s. The maximal radial imaging depth is
up to 10 cm and the maximal axial resolution approximately
0.2 to 0.3 mm. The imaging catheter was advanced to the
high right atrium via a femoral venous approach using an
11F Mullins sheath. Right atrial imaging planes are cross-
sectional views 10° oblique (posterior-superior and anterior-
inferior) of the SVC-IVC axis (Fig. 1). The view used for
IST ablation was at the level of the SVC-RA junction,
which demonstrates the superior crista terminalis (Fig. 1).
The SVC-RA junction was defined by the confluence of the
SVC, right atrium and right atrial appendage. In this
imaging plane, the superior medial crista terminalis is
demonstrated just lateral to the ascending aorta and just
anterior to the right pulmonary artery. In this same view,
the superior lateral crista terminalis can also be demon-
strated, at the orifice of the right atrial appendage (Fig. 1).
The SVC-RA orifice was measured in end-systole as the
distance between the superior medial and superior lateral
crista terminalis. In addition, ICE imaging was used con-
tinuously throughout the procedure to guide ablation cath-
eter placement and assess electrode-tissue contact.
The orifice diameter of the SVC-RA junction was
measured prior to and following RF lesion delivery. Data
analysis was performed in a retrospective fashion. The
SVC-RA junction measurements were performed on iden-
tical views pre- and postablation; in addition to the speci-
ficity of the anatomic landmarks, control measurements of
the SVC lumen pre- and postablation were compared to
Abbreviations and Acronyms
ICE 5 intracardiac echocardiography
IST 5 inappropriate sinus tachycardia
RF 5 radiofrequency
SVC 5 superior vena cava
SVC-RA 5 superior vena cava–right atrial
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ensure that identical views were compared. Intraobserver
variability with repeated measurements was #4%. The
primary variable used for analysis was the percentage reduc-
tion of the SVC-RA orifice [(pre-post)/pre-measurement]
caused by the delivery of RF lesions.
Statistical analysis. Data are presented as mean values 6
SD. Comparison of SVC-RA orifice size before and fol-
lowing RF lesions was performed using the paired Student
t test.
RESULTS
Acute procedural success, defined by abrupt slowing of
the sinus rate and transition to a superiorly directed p-wave
morphology in lead III, was achieved in 11 of 13 procedures
and required a mean of 29 6 20 RF applications (range 5 to
69). No procedural complications were observed. One
patient required pacemaker implantation following com-
plete sinus node ablation.
Before the delivery of RF lesions, the orifice of the
SVC-RA junction measured 16.4 6 2.9 mm (Table 1). The
RF energy delivery caused tissue swelling at the site of
catheter contact as well as circumferential swelling around
the SVC-RA junction with resultant decrease in the diam-
eter of the SVC-RA junction orifice. In general, tissue
swelling in the SVC-RA junction increased with time
during the procedure and with the delivery of sequential
lesions; the reduction in orifice diameter did not correlate
with the number of lesions delivered, however. Following
the last RF lesion delivered, the orifice measured 12.6 6
3.3 mm (24% reduction, p 5 0.0001; Fig. 1). A reduction in
SVC-RA orifice diameter of $30% compared with baseline
was observed in five patients.
Superior vena cava occlusion and clinical signs of SVC
syndrome were not observed. Small adherent thrombi were
identified within crater lesions in four patients, but did not
contribute significantly to SVC-RA isthmus reduction.
Recovery of tissue swelling within the SVC-RA junction
was not observed during ICE monitoring for 30 min
following the delivery of the final RF lesion. In the three
patients who required repeat procedures (range: one to eight
months between procedures), no evidence of persistent
tissue swelling at the SVC-RA junction was observed
(SVC-RA junction 17.0 6 3.0 mm and 16.3 6 1.5 mm
prior to first and second procedures, respectively; p 5 NS).
DISCUSSION
Delivery of multiple RF lesions, often required for cure of
IST, causes significant tissue swelling at the SVC-RA
junction, an area that serves as the inlet to the right atrium.
This swelling is most marked at the site of RF delivery, but
also occurs throughout the entire circumference of the
SVC-RA junction, presumably through spread of intersti-
tial edema through the contiguous tissue space. Some
degree of tissue swelling is essential for therapeutic lesion
delivery (5,12,13); extensive swelling can prevent adequate
catheter contact with the crista terminalis and may produce
critical narrowing at venous ostia. This tissue swelling and
resultant narrowing of the SVC-RA junction persists
throughout the time span of the ablation procedure, but
appears to resolve within weeks to months. Animal studies
have demonstrated that right atrial tissue thickening follow-
Figure 1. Narrowing of the SVC-RA junction with RF delivery.
The ICE images are 10° oblique cross-sectional views oriented
such that the ultrasound transducer is in the center of the image,
posterior and superior structures are at the top of the image,
anterior and inferior structures at the bottom and right-sided
(lateral) structures to the viewer’s right. The arrows refer to the
SVC-RA junction at the level of the superior lateral crista
terminalis. In the left frame, the SVC-RA junction is shown at
baseline (arrows). After RF delivery to the lateral crista terminalis
(right frame), circumferential tissue swelling was noted, with a
40% reduction in the SVC-RA junction. The open arrowhead
demonstrates a crater at RF lesion site. Ao, aorta; c, catheter; RPA,
right pulmonary artery; RAA, right atrial appendage; SVC, supe-
rior vena cava.
Table 1. Patient Characteristics, SVC-RA Orifice
Measurements and Ablation Outcome
Patient
Age (yr)/
Gender
SVC-RA Orifice
(mm)
No.
RF Success
Pre-
RF
Post-
RF
%
Reduction
1 45/F 15 11 27 23 yes
2a 36/F 16.5 14 15 5 yes
2b 17.5 10.5 40 17 yes
3 25/M 19 16 16 19 yes
4 26/F 15 10.5 30 19 yes
5 33/F 13 8 26 26 yes
6 32/F 11 7 36 44 yes
7 24/F 21 16 34 48 yes
8a 29/F 19.5 17 13 14 no
8b 16 13 19 14 yes
9 20/F 19 17 11 52 yes
10a 20/F 13.5 11 18 69 no
10b 15 12 26 8 yes
1669JACC Vol. 33, No. 6, 1999 Callans et al.
May 1999:1667–70 Intracardiac Echo During Sinus Node Modification
ing radiofrequency application increases with time and
persists for at least 150 min (13). Although SVC occlusion
was not observed, the characteristics of the tissue swelling at
the SCV-RA junction observed in this study support the
conclusion that RF-induced tissue swelling is a plausible
mechanism for this complication.
The enthusiasm for catheter ablation techniques is justi-
fiable, given the low incidence of adverse events and the
high efficacy in many arrhythmia syndromes (7,14–17).
Nonetheless, as catheter ablation techniques are being
applied in the hope of curing more challenging arrhythmias,
a careful ongoing assessment of the risk/benefit balance is
essential. The possibility of significant procedural morbid-
ity, including damage to contiguous vascular structures such
as the aorta and coronary arteries, has been suggested
(18–21). The occurrence of SVC occlusion as well as
pulmonary venous occlusion leading to the development of
pulmonary hypertension (9) underscores the potential for
clinically important complications of RF-induced tissue
swelling. The ICE imaging using currently available tech-
nology allows for continuous monitoring of intracardiac and
contiguous vascular structures and may prove helpful in the
avoidance of adverse effects of RF-induced tissue swelling.
Although the current study, with its retrospective design,
does not present data on the use of ICE to avoid adverse
events, it does demonstrate the feasibility of the technique
in monitoring the SVC-RA junction during ablation of
IST. Further investigation will be required to determine the
efficacy of ICE imaging in preventing procedural complica-
tions related to tissue swelling.
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